retatrutide fda approval status as of october 2025 Retatrutide Weight Loss Results Trial Data and FDA Status

The FDA has warned six online companies for selling compounded retatrutide, an unlicensed weight-loss drug that has gained traction among social media influencers., "All of a sudden, you have

27.92

★★★★☆4.8 (126)

The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight-loss results, Retatrutide

21.81

★★★★★4.9 (98)

FDA Warns Companies Over Compounded Retatrutide: What Healthcare Providers Should Know

22.82

★★★★★5.0 (157)

The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight-loss results, Retatrutide

23.35

★★★★★4.7 (84)

Retatrutide FDA Approval: 3 Scenarios That Change Everything

24.46

★★★★★4.9 (203)

Will the FDA approve retatrutide? Odds & Predictions

22.34

★★★★★5.0 (176)

Trial of next-gen weight-loss drug retatrutide brings it one step closer to FDA approval

25.36

★★★★★4.8 (132)